# DemeRx, Inc.: Form D filings

DemeRx, Inc., a pharmaceuticals company in Fort Lauderdale, FL, filed 6 Form D notices with the SEC between 2010 and 2015. The latest, on May 8, 2015, reports $289,569 sold of a $499,998 offering to 9 investors.

Find out what DemeRx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20DemeRx%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=DemeRx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fdemerx-inc-1489594)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20DemeRx%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=DemeRx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fdemerx-inc-1489594)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Florida](https://specstream.ai/data/form-d/state/florida): 2,702 rows, by operating companies, filed since November 1, 2024, $107.02, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/florida
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 305 South Andrews Ave, Suite 515, Fort Lauderdale, FL, 33301
- Phone: (954) 607-3670
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Florida
- Year incorporated: 2010
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1489594

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 8, 2015 | New notice | $499,998 | $289,569 | $210,429 | 9 | Apr 14, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959415000001/0001489594-15-000001-index.htm) |
| Mar 1, 2013 | Amendment | $11,000,000 | $5,137,028 | $5,862,972 | 35 | Sep 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959413000002/0001489594-13-000002-index.htm) |
| Feb 27, 2013 | Amendment | $11,000,000 | $5,137,028 | $5,862,972 | 35 | Sep 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959413000001/0001489594-13-000001-index.htm) |
| Sep 4, 2012 | New notice | $8,250,000 | $0 | $8,250,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959412000002/0001489594-12-000002-index.htm) |
| Jun 21, 2010 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959410000002/0001489594-10-000002-index.htm) |
| May 3, 2010 | New notice | Indefinite | $85 | Indefinite | 5 | Apr 19, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489594/000148959410000001/0001489594-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Henry L. Mellon | Director |  |
| Holger L. Weis | Executive Officer |  |
| Jeffrey L. Raney | Executive Officer |  |
| Charles L. Koob | Director |  |
| Bruce L. Hack | Director |  |
| Peter L. Nejes | Director |  |
| Steve L. Gorlin | Director |  |
| Skip L. Clemmons | Director |  |

## Other pharmaceuticals companies in Florida that filed recently

- [GOA Therapeutics Corp](https://specstream.ai/data/form-d/company/goa-therapeutics-corp-2131824) $300,000 · Nov 5, 2026
- [DalCor Pharmaceuticals US, LLC](https://specstream.ai/data/form-d/company/dalcor-pharmaceuticals-us-llc-1673368) $7 million · Aug 28, 2026

[Every Form D from the week of May 4, 2015](https://specstream.ai/data/form-d/week/2015-05-04) · [All recent filings in Florida](https://specstream.ai/data/form-d/state/florida) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what DemeRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).